Cogan's Syndrome Combined with Hypertrophic Pachymeningitis: A Case Report
Ci Lu,Panpan Lv,Xiaoying Zhu,Yongmei Han
DOI: https://doi.org/10.2147/jir.s453071
IF: 4.5
2024-03-20
Journal of Inflammation Research
Abstract:Ci Lu, 1, &ast Panpan Lv, 2, &ast Xiaoying Zhu, 1 Yongmei Han 1 1 Department of Rheumatology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China; 2 Department of Ultrasound, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiaoying Zhu; Yongmei Han, Department of Rheumatology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 3&num Qingchun East Road, Hangzhou, 310016, People's Republic of China, Email ; Cogan's syndrome (CS) is a rare chronic inflammatory disease, characterized by interstitial keratitis and vestibular auditory dysfunction. Hypertrophic pachymeningitis (HP) is a rare chronic aseptic inflammatory disease of the central nervous system. This article reports a patient with CS coexisting with HP. The patient was a 66-year-old male with fever, headache, red eyes, hearing loss, and significantly elevated inflammatory markers. Cerebrospinal fluid examination, blood culture, and tests for autoantibodies such as antinuclear antibodies were negative. Pure tone audiology (PTA) indicated bilateral sensorineural deafness. Both Positron emission tomography–computed tomography (PET/CT) and vascular color Doppler ultrasound suggest the presence of vasculitis. Considering Cogan's syndrome, the patient received 40 mg of methylprednisolone intravenously once daily. The brain's magnetic resonance imaging (MRI) revealed slightly thickened and enhanced dura mater, suggesting HP. The dose of methylprednisolone was increased to 40 mg intravenously every 8 hours, leading to the patient's improved symptoms and decreased inflammatory markers. Both CS and HP are rare chronic inflammatory diseases, and their coexistence is even rarer, with only two reported cases in literature up to date. The coexistence of CS and HP should be considered when the CS patients with headaches do not respond well to treatment. Keywords: Cogan's syndrome, hypertrophic pachymeningitis, vasculitis Cogan's syndrome (CS) is a rare chronic inflammatory disease characterized by eye and vestibuloauditory dysfunction. The most common ocular manifestation of CS is interstitial keratitis. But it may also present itself with conjunctivitis, iridocyclitis, scleritis, retinal vasculitis, etc. Vestibuloauditory dysfunction mainly manifests as Ménière's-like attacks, including dizziness, ataxia, and hearing loss. CS may also involve systemic vasculitis, among which aortic inflammation is the most common. 1 It can be divided into typical CS (the interval between the onset of ocular and audiovestibular manifestations is less than 2 years) and atypical CS (the interval between the onset of typical ocular and audiovestibular manifestations is more than 2 years). Hypertrophic pachymeningitis (HP) is a chronic non-infectious inflammatory disease characterized by thickening of the dura mater. It is divided into two major categories: idiopathic and secondary. Secondary HP can occur in various diseases, such as infections (such as neurosyphilis or fungal meningitis), inflammatory diseases (IgG4-related diseases, ANCA-associated vasculitis), and tumors (such as dural metastases and meningiomas). 2 The incidence of CS or HP is low, and their simultaneous occurrence is even rarer. So far, only two case reports have been published. 3,4 The 66-year-old male patient was admitted to the hospital in January 2022 with a chief complaint of "recurrent fever and headache for more than a month". One month before admission, the patient experienced headaches, nasal congestion, and fatigue. After that, he developed a fever with a temperature of around 38.5°C, accompanied by mild cough with a small amount of white sticky phlegm. Additionally, the patient had bilateral eyelid edema, redness, and blurry vision. About a week later, tinnitus with hearing loss was worse than before. The patient's C-reactive protein (CRP) level increased progressively (46–63.4-141-146mg/L). In the meanwhile, blood culture, sputum culture, and cerebrospinal fluid tests were all normal. The patient was treated with levofloxacin, moxifloxacin, piperacillin/tazobactam, and imipenem/cilastatin without improvement. The patient had a history of stroke 5 years ago, hypertension for 2 years, and diabetes for 1 month. No family or genetic history. Physical examination showed conjunctival congestion and swelling in both eyes. Several enlarged lymph nodes with slightly hard textures were palpable on both sides of the neck, which were mobile and non-tender. No other enlarged superficial lymph nodes were found. The heart and lungs were normal, and no abnormalities were detected in the abd -Abstract Truncated-
immunology